[Use of hemostatic preparations in obstetrical hemorrhages].
D000347:Afibrinogenemia / Q000188:drug therapy; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001803:Blood Transfusion; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006487:Hemostasis / Q000187:drug effects; D006489:Hemostatic Techniques; D006490:Hemostatics / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008428:Maternal Mortality; D007744:Obstetric Labor Complications / Q000188:drug therapy*; D011247:Pregnancy; D011479:Protamines / Q000627:therapeutic use; D011644:Puerperal Disorders / Q000188:drug therapy; D014592:Uterine Hemorrhage / Q000188:drug therapy*
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D011479:Protamines; D006493:Heparin
Zastosuvannia hemostatychnykh preparativ pry akushers'kykh krovotechakh